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Abstract
Background: Protein-tyrosine phosphatase 1B (PTP1B) is a physiological regulator of glucose homeostasis and body mass,
and has been implicated in endoplasmic reticulum (ER) stress. Herein, we assess the role of PTP1B in ER stress in brown
adipocytes, which are key regulators of thermogenesis and metabolic response.
Methodology/Principal Findings: To determine the role of PTP1B in ER stress, we utilized brown adipose tissue (BAT) from
mice with adipose-specific PTP1B deletion, and brown adipocytes deficient in PTP1B and reconstituted with PTP1B wild type
(WT) or the substrate-trapping PTP1B D181A (D/A) mutant. PTP1B deficiency led to upregulation of PERK-eIF2a
phosphorylation and IRE1a-XBP1 sub-arms of the unfolded protein response. In addition, PTP1B deficiency sensitized
differentiated brown adipocytes to chemical-induced ER stress. Moreover, PERK activation and tyrosine phosphorylation
were increased in BAT and adipocytes lacking PTP1B. Increased PERK activity resulted in the induction of eIF2a
phosphorylation at Ser51 and better translatability of ATF4 mRNA in response to ER stress. At the molecular level, we
demonstrate direct interaction between PTP1B and PERK and identify PERK Tyr615 as a mediator of this association.
Conclusions: Collectively, the data demonstrate that PTP1B is a physiologically-relevant modulator of ER stress in brown
adipocytes and that PTP1B deficiency modulates PERK-eIF2a phosphorylation and protein synthesis.
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Introduction
Metabolic syndrome, cardiovascular disease and type 2 diabetes
are complex disorders that are associated with obesity and
sedentary life style [1,2]. The mechanisms by which excess
nutrients and adiposity trigger changes that lead to these chronic
diseases are still being elucidated. Endoplasmic reticulum (ER) is
an organelle that is highly responsive to nutrient and energy status
of the cell and plays an important role in folding and maturation of
newly synthesized proteins. ER dysfunction is a major contributor
to metabolic disease [3,4]. When the folding capacity of the ER is
exceeded, misfolded/unfolded proteins accumulate and lead to
ER stress [5]. Notably, prolonged high fat-feeding and genetic
obesity in mice lead to increased ER stress in liver and adipose
tissue [3]. Importantly, obese individuals exhibit increased
expression of multiple markers of ER stress in adipose tissue [6].
However, it is not presently clear whether ER dysfunction is a
cause or an effect of obesity. Thus, understanding the function of
ER stress in insulin resistance and obesity may be of therapeutic
potential for the treatment of metabolic disorders.
Cells use adaptive mechanisms to counter the deleterious effects
of ER stress known as the unfolded protein response (UPR) [7].
UPR consists of three branches that are controlled by the ER
transmemberane proteins PKR-like ER-regulated kinase (PERK),
inositol requiring protein 1a (IRE1a), and activating transcription
factor 6 (ATF6) [4,8,9]. These sensor proteins respond to changes
in protein-folding status and activate distinct and sometimes
overlapping pathways. PERK phosphorylates the a-subunit of
translation initiation factor 2 (eIF2a) at serine 51, a modification
that blocks initiation of mRNA translation in response to ER stress
[10–12]. PERK is a serine/threonine kinase whose autophospho-
rylation at threonine (Thr980) within its activation loop is essential
for its activation and eIF2a phosphorylation [11]. However,
PERK is a tyrosine phosphorylated protein [13] and its activity is
regulated by tyrosine phosphorylation in as much as autophos-
phorylation of PERK at tyrosine 615 is required for maximal
kinase activity in vitro and in vivo [14]. IRE1a activation leads to the
unconventional splicing of X-box binding protein 1 (XBP1)
mRNA leading to the synthesis of a nuclear XBP1 form which
induces the transcription of genes encoding ER chaperones [15–
17]. The third canonical branch of ER stress signaling includes the
ATF6 transcription factors [18,19]. These UPR arms synergize to
attenuate stress by increasing the folding capacity of the ER
through mechanisms that involve translational attenuation,
regulation of ER biogenesis as well as ER-associated protein
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degradation [5]. However, if the compensatory mechanisms fail to
restore homeostasis, ER stress-insuced apoptosis commences
[20,21].
Protein-tyrosine phosphatase 1B (PTP1B) is a widely expressed
non-receptor tyrosine-specific phosphatase that is localized on the
cytoplasmic face of the ER [22–24]. PTP1B is a physiological
regulator of glucose homeostasis and energy balance. Specifically,
whole-body PTP1B knockout (KO) mice are hypersensitive to
insulin, lean and resistant to high fat diet (HFD)-induced obesity
[25,26]. PTP1B has been implicated in the regulation of ER stress
signaling. Mouse embryonic fibroblasts lacking PTP1B exhibit
impaired IRE1a signaling and attenuated ER stress-induced
apoptosis [27]. In addition, liver-specific PTP1B deficiency
protects mice against HFD-induced ER stress [28,29]. On the
other hand, PTP1B overexpression in insulinoma MIN6 b-cells
mitigates chemical-induced PERK/eIF2a signaling, and PTP1B
deficiency increases ER stress-induced cell death [30]. However,
the role of PTP1B in regulating ER stress in the adipose tissue
remains unexplored.
Adipose tissue integrates an array of homeostatic processes and
is a regulator of systemic insulin sensitivity and energy metabolism
[31]. White adipose tissue (WAT) is the primary site for
triglyceride storage or fatty acid release in response to energy
requirements whereas brown adipose tissue (BAT) generates heat
via mitochondrial uncoupling of lipid oxidation [32]. BAT is a
thermogenic tissue with an established role in the defense against
cold, a process known as non shivering thermogenesis [33]. In
addition, BAT is recognized for its anti-obesity properties given
that mice with increased BAT gain less weight, are more insulin
sensitive, and are protected from diabetes [34–37]. Interest in
BAT has gained traction from recent findings that humans have
Figure 1. Enhanced UPR in PTP1B-deficient BAT. (A) Immunoblots of p-PERK (Thr980), PERK, p-eIF2a (Ser51), eIF2a, BiP, sXBP1, cATF6a and
CHOP in BAT lysates of Adipoq-Cre, fl/fl and adipose-PTP1B deficient (KO) mice fed HFD (for 26 weeks). Lysates were also probed for PTP1B to
evaluate deletion efficiency, and Tubulin to control for loading. Each lane represents brown adipose tissue from a different animal. Bar charts
represent p-PERK (Thr980) and p-eIF2a (Ser51) normalized to their protein expression, BiP, sXBP1, cATF6a normalized to Tubulin, from three
independent experiments. (B–D) BiP, sXBP1 and CHOP mRNA was measured by quantitative real-time PCR and normalized against GAPDH in BAT
from the same cohort of mice. Data represent means 6 SEM from at least three different mice per genotype. (*) indicates significant difference
between KO and fl/fl, and (#) indicates significant difference between KO and Cre.
doi:10.1371/journal.pone.0034412.g001
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BAT depots and that their activity varies depending on adiposity,
temperature, and age [38–41].
In this study, we investigated the role of PTP1B in ER stress
signaling in brown adipocytes. We utilized BAT and brown
preadipocyte cell lines lacking PTP1B to investigate its role in
regulating UPR and in particular PERK-eIF2a phosphorylation
in response to ER stress.
Results
PTP1B deficiency enhanced UPR in BAT and in
differentiated brown adipocytes
Obese rodents and humans exhibit increased ER stress in
adipose tissue [3,6]. Understanding the role of adipose tissue ER
stress in metabolic regulation may be of therapeutic potential.
BAT is a thermogenic tissue that is recognized for its anti-obesity
properties [34–36]. We recently demonstrated that PTP1B is a
modulator of brown fat adipogenesis through a PPARc-dependent
mechanism and that brown adipocyte differentiation requires
regulated expression of PTP1B [42].
We initially investigated the effects of ER stress induction on
PTP1B protein expression in adipose tissue and adipocytes. Mice
fed a HFD exhibited significant increase in PTP1B expression in
BAT and WAT depots compared with those fed standard chow
diet (Fig. S1A). In addition, palmitate treatment of differentiated
brown and white adipocytes led to significant increase in PTP1B
expression compared with untreated control (Fig. S1B). To address
the role of PTP1B in adipose tissue ER stress, we utilized mice
with adipose-specific PTP1B deletion. Adipose-deficient PTP1B
mice were generated by crossing PTP1Bfl/fl (fl/fl) mice to those
expressing Cre recombinase under the control of the adiponectin
locus (Adipoq-Cre). The resulting Adipoq-Cre PTP1Bfl/+ mice
were crossed to PTP1Bfl/fl mice, yielding Adipoq-Cre PTP1Bfl/fl
(hereafter termed KO). Control (Cre and fl/fl) and KO mice were
maintained on HFD for 26 weeks. KO mice exhibited significant
(,80%) PTP1B deletion in BAT; the residual PTP1B expression
in KO BAT likely reflects expression in other cell types in adipose
tissue, such as vascular endothelial cells and macrophages (Fig. 1A).
Induction of UPR in BAT by high fat feeding was assessed by
immunoblot analysis of specific markers of ER stress. PTP1B
deficient BAT exhibited increased PERK activity as indicated by
enhanced PERK autophosphorylation at Thr980 as well as
elevated phosphorylation of its substrate eIF2a at Ser51 compared
with control mice (Fig. 1A). Expression of the molecular
chaperone BiP was also increased in PTP1B deficient BAT
compared with control. In addition, PTP1B deficiency resulted in
increased expression of spliced XBP1, cleaved ATF6a and CHOP
proteins (Fig. 1A). Moreover, BiP, sXBP1 and CHOP mRNAs
were also upregulated in PTP1B deficient BAT compared with
control (Fig. 1B–D). Consistent with findings in BAT, subcutane-
ous WAT depot of KO mice exhibited increased PERK Thr980
and eIF2a Ser51phosphorylation and increased BiP, sXBP1,
cATF6a and CHOP expression compared with control (Fig. S2A).
In addition, retroperitoneal WAT depot of KO mice exhibited
increased PERK Thr980 and eIF2a Ser51 phosphorylation and
increased cATF6a and CHOP expression compared with control
(Fig. S2B).
To determine whether the effects of PTP1B deficiency in BAT
on UPR were cell autonomous, we utilized previously generated
brown preadipocyte cell lines [42,43]. Briefly, immortalized brown
preadipocytes were generated from whole-body PTP1B KO mice
and reconstituted with human (h) PTP1B (WT). It is noteworthy
that hPTP1B shares a high degree of homology to mouse (m)
PTP1B and functionally complements the loss of mPTP1B in
mouse embryonic fibroblasts [44]. In addition, KO cells were
reconstituted with substrate-trapping hPTP1B D181A (D/A)
mutant that retains substrate binding but is catalytically impaired
[42,43]; therefore the mutant forms stable complexes with
tyrosine-phosphorylated substrates. Differentiation of KO and
reconstituted (WT and D/A) preadipocytes was performed as
previously described [42,43]. ER stress was induced in differen-
tiated adipocytes by treatment with thapsigargin (TG) or
tunicamycin (TN) [45,46]. Treatment with TG resulted in higher
PERK Thr980 and eIF2a Ser51 phosphorylation, BiP and CHOP
expression in KO and D/A adipocytes compared with WT
(Fig. 2A). In addition, increased BiP, sXBP1 and CHOP mRNA in
response to ER stress was more evident in KO and D/A
adipocytes compared with WT (Fig. 2B–D). Comparable findings
were observed in TN-treated adipocytes indicating that the effects
are not limited to TG-induced ER stress (Fig. S3). Together, these
data demonstrate enhanced UPR in BAT and adipocytes lacking
PTP1B.
Adipose PTP1B deficiency increased PERK tyrosine
phosphorylation
Considering that tyrosine phosphorylation of PERK is required
for optimal kinase activity [13,14] and the function of PTP1B as a
tyrosine phosphatase, we investigated whether PTP1B regulates
PERK tyrosine phoshorylation. PERK was immunoprecipitated
from BAT lysates of adipose-PTP1B KO and control mice and
immunoblotted using anti-phosphotyrosine antibodies or phospho-
specific antibodies that detect PERK Tyr615 and Thr980. PTP1B
deficient BAT revealed increased overall PERK tyrosine phos-
phorylation compared with controls (Fig. 3A). In addition, PERK
Tyr615 and Thr980 phosphorylation was enhanced in PTP1B
deficient BAT compared with controls. In line with these
observations, PERK overall tyrosine phosphorylation was in-
creased in thapsigargin-treated KO and D/A adipocytes com-
pared with WT (Fig. 3B). Togther, these data indicate inverse
relationship between PTP1B activity and tyrosine phosphorylation
of PERK in brown adipocytes.
These findings prompted us to examine whether PERK is a
direct substrate of PTP1B. To that end, we transiently co-
expressed wild type and substrate-trapping PTP1B (D/A) with
wild type Myc-PERK in PTP1B KO preadipose cells and
subjected to TG-induced ER stress. Cells were lysed as described
in Methods and immunoprecipitates of PTP1B were probed for
PERK using anti-Myc antibodies (Fig. 3C). No association
between PERK and PTP1B WT was observed given the transient
nature of PTP1B WT-substrate interactions. On the other hand,
PERK co-immunoprecipitated only with PTP1B D/A at basal
and TG-treated conditions, and co-association increased signifi-
cantly after TG treatment. Notably, treatment with pervanadate
(indicated with v in Fig. 3C), a strong inhibitor of tyrosine
phosphatases, which oxidizes the essential cysteinyl residue in the
catalytic center of the enzymes [47] disrupted PERK and PTP1B
D/A interaction. This suggested that the association is consistent
with enzyme-substrate interaction that is mediated by the active
site cysteinyl residue. Given the increased phosphorylation of
PERK Tyr615 in adipocytes lacking PTP1B, we tested the
importance of this residue in mediating association with PTP1B
D/A. PTP1B D/A was co-expressed with Myc-PERK WT and
Myc-PERK Y615F mutant in PERK2/2 fibroblasts, and
subjected to TG-induced ER stress. Wild type PERK co-
immunoprecipitated with PTP1B D/A as expected but mutation
of Tyr615 abrogated PERK association with PTP1B D/A
(Fig. 3C).
PTP1B and Brown Adipose ER Stress
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To evaluate the cellular dynamics of PTP1B and PERK in
response to ER stress, we transiently co-expressed Cherry-
PTP1B WT or Cherry-PTP1B D/A with Myc-PERK (WT or
Y615F) in brown preadipocytes and monitored their sub-cellular
localization under basal and TG-induced ER stress using
confocal microscopy (Fig. 3D). Consistent with previous reports
[22,23,48], PTP1B and PERK localized to the ER network. In
addition, wild type PERK co-localized with PTP1B D/A under
basal and TG-treated conditions. Notably, mutating Tyr615 in
PERK significantly attenuated co-localization with PTP1B D/A
in line with biochemical data. Collectively, these data estab-
lished PERK as a direct substrate for PTP1B in adipocytes and
revealed that the interaction is mediated through PERK
Tyr615.
PTP1B deficiency increased ATF4 translation in brown
adipocytes
eIF2a Ser51 phosphorylation plays a critical role in blocking
translational initiation [49]. Paradoxially, eIF2a phosphorylation
increases translation of ATF4 mRNA to produce a transcription
factor that activates expression of several UPR target genes [50].
The observed increase in eIF2a phosphorylation in BAT and
adipocytes lacking PTP1B prompted us to examine the transla-
tional effects of PTP1B on endogenous ATF4 mRNA in response
to ER stress. Differentiated KO and WT brown adipocytes were
subjected to polysome profile analysis, a technique that allows the
separation of monosomes from polyribosomes by sucrose density
centrifugation [51] (Fig. 4). Efficiently translated mRNAs are
bound to polyribosomes (polysomes) whereas poorly translated
mRNAs are detected in fractions with monosomes. Under basal
conditions, we observed that a larger amount of ATF4 mRNAs
Figure 2. Enhanced PERK/eIF2a phosphorylation in PTP1B-deficient brown adipocytes. Differentiated brown adipocytes were treated
with thapsigargin (TG; 1 mM) for the indicated times. (A) Immunoblots of p-PERK (Thr980), PERK, p-eIF2a (Ser51), eIF2a, BiP and CHOP in lysates of
differentiated WT, KO and D/A adipocytes. BiP (B), sXBP1 (C) and CHOP (D) mRNA was measured by quantitative real-time PCR and normalized
against GAPDH. Data represent means 6 SEM of three independent experiments. (*) indicates significant difference between KO and D/A versus WT
at the corresponding time, (#) indicates significant difference between treated and non-treated cells within each group, and (‘) indicates significant
difference between KO and D/A at the corresponding time.
doi:10.1371/journal.pone.0034412.g002
PTP1B and Brown Adipose ER Stress
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was associated with polyribosomes in PTP1B KO adipocytes
compared with WT (Fig. 4A, C). Upon treatment with TG, we
observed that the ATF4 transcripts shifted towards larger
polyribosomes in both cell types (Fig. 4B, D) indicating their
efficient translation as a result of PERK activation and eIF2a
phosphorylation. Interestingly, however, a significant fraction of
ATF4 mRNA shifted to heavier polysomes in TG-treated KO cells
compared with WT cells. This difference in ATF4 mRNA
translation is consistent with the higher eIF2a phosphorylation
in TG-treated KO adipocytes than in WT.
To determine protein synthesis in WT, KO and D/A
adipocytes, we used 35S-methionine metabolic labelling as
described in Methods. Under basal condition, KO and D/A
adipocytes exhibited lower protein synthesis compared with WT
(Fig. 4E). TG treatment drastically diminished protein synthesis by
45% in WT cells, and resulted in greater reduction (60 and 50%)
in KO and D/A cells, respectively. These findings are consistent
with eIF2a Ser51 phosphorylation and polysome profile analyses
in these cells. Together, our data indicate that the control of
PERK-eIF2a phosphorylation by PTP1B in brown adipocytes
signals to translational machinery through the regulation of the
translatability of ATF4 mRNA in the absence as well as presence
of ER stress.
Discussion
PTP1B is a physiological regulator of systemic glucose
homeostasis and energy balance. Given the salutary effects of
whole-body PTP1B deficiency, it is an attractive target for therapy
of diabetes and/or obesity. Obesity leads to increased ER stress in
insulin-responsive tissues [3,6], but the precise contribution of ER
stress to metabolic regulation, and modulation of ER stress by
PTP1B requires additional investigation. In this study, we
identified PTP1B as a key regulator of PERK/eIF2a sub-arm of
ER stress signaling in brown adipocytes. We demonstrated
enhanced phosphorylation and activation of PERK and eIF2a
in BAT of mice lacking PTP1B challenged with HFD and in
differentiated brown adipocytes treated with thapsigargin and
tunicamycin. At the molecular level, we uncovered direct
interaction between PERK and PTP1B in adipocytes. PERK is
modified by tyrosine phosphorylation and its tyrosine phosphor-
ylation is highly induced in response to ER stress [14]. Indeed, our
biochemical studies revealed significant co-association between
PERK and the substrate-trapping mutant PTP1B D/A at basal
conditions. Increased tyrosine phosphorylation of PERK after TG
treatment resulted in concomitant increase in PERK-PTP1B D/A
co-association. Of note, PTP1B-PERK association is consistent
with enzyme-substrate interaction that is mediated by the active
site cysteinyl residue of PTP1B since pervanadate treatment
disrupts the interaction. In addition, we identified PERK Tyr615
as a key mediator of interaction with PTP1B. Notably, PERK
Tyr615 phosphorylation is required for maximal kinase activity in
vitro and in vivo [14]. In line with increased PERK phosphorylation
in adipocytes lacking PTP1B, eIF2a Ser51 phosphorylation was
elevated resulting in better translatability of ATF4 mRNA.
Prior reports indicated that deletion of PTP1B in liver can
reduce activation of PERK (Thr980 phosphorylation) and eIF2a
phosphorylation in response to certain stresses such as high fat
diet, suggesting that PTP1B potentially promotes activation of
PERK [28,29]. Similarly, mouse embryonic fibroblasts lacking
PTP1B exhibit impaired IRE1a signaling and attenuated ER
stress-induced apoptosis [27]. By contrast, our current studies
show clearly that PTP1B deficiency enhanced PERK/eIF2a sub-
arm of ER stress response in BAT and adipocytes. These findings
are in line with previous studies in MIN6 insulinoma b-cells where
PTP1B deficiency enhances palmitate- or tunicamycin-induced
PERK/eIF2a ER stress signaling, whereas PTP1B overexpression
suppresses this ER stress response [30]. Related to these findings,
recent elegant studies demonstrate that PTP1B is inhibited by
sulfhydration in response to endogenously generated hydrogen
sulfide [52]. Importantly, PTP1B inhibition directly promotes
PERK activity (and Tyr615 phsophorylation) during the response
to ER stress [52]. The reason(s) for discrepancies between the
studies is currently not clear. Conceivably, PTP1B has distinct
substrates and/or regulates distinct arms of ER stress signaling in
different tissues and in response to various challenges. Alterna-
tively, PTP1B may affect the same pathways in different tissues,
but the effects of those pathways may differ in a tissue-specific
manner. Indeed, induction of ER stress in adipocytes and liver
cells using protease inhibitors leads to downregulation of lipogenic
genes in adipocytes and upregulation in hepatocytes [53]. Finally,
it is worth noting that the effects of PTP1B on ER stress response
could be general; caused by indirect regulation of one or more sub-
arm of ER stress pathway, and/or specific; caused by direct
regulation of PERK signaling.
In summary, we identified PTP1B as a key regulator of PERK/
eIF2a signaling and established PERK as a direct substrate of
PTP1B in adipocytes. Importantly, we determined functional cross
talk between PTP1B and PERK, and demonstrated that PTP1B
deficiency in adipocytes regulates the translational machinery by
directly modulating PERK signaling. Of note, we cannot rule out
that PTP1B-PERK interaction leads to regulation of PTP1B
activity by PERK. This may be implied by findings that PKR can
stimulate the activity of the closely-related T cell PTP [54]. At any
rate, our findings provided new insights into the regulation of
adipocyte ER stress signaling by PTP1B. Additional studies will
provide further insights into the complex regulation of ER stress by
PTP1B in various tissues and in response to different challenges,
and decipher its contribution to metabolic regulation.
Figure 3. PTP1B dephosphorylation of PERK. (A) PERK was immunoprecipitated from BAT lysates of Cre, fl/fl and adipose-PTP1B KO (KO) male
mice fed HFD for 30 weeks, and then immunoblotted with anti-phosphotyrosine antibodies, phospho-specific antibodies for PKR Tyr293 (PERK Y615)
and PERK (Thr980). Blots were also probed for PERK to control for loading. Each lane represents brown adipose tissue from a different animal. (B)
Differentiated WT, KO and D/A brown adipocytes and PERK2/2 and PERK+/+ fibroblasts were treated with thapsigargin (TG) for the indicated times.
Immunoprecipitates of PERK were immunoblotted with anti-phosphotyrosine antibodies. Blots were also probed for PERK to control for loading. (C)
PTP1B KO preadipose cells were co-transfected with PTP1B WT and substrate-trapping D181A mutant (D/A) and Myc-tagged PERK wild type. In
addition, PERK KO fibroblasts were co-transfected with PTP1B D/A and Myc-tagged PERK WT and Y615F mutant. Cell were treated with TG for the
indicated times then lysed in NP40 or RIPA (R), with or without pervanadate (V) treatment. Lysates were immunoprecipitated using mouse (m) and
human (h) PTP1B antibodies and immunoblotted using anti-c-Myc and anti-(m/h) PTP1B antibodies. (D) PTP1B KO brown preadipocytes were
transfected with hPTP1B WT, or hPTP1B D/A (red) and c-Myc-PERK WT or Y615F mutant (green), treated with thapsigargin (TG) for 2 hours and
visualized by fluorescence confocal microscopy. Scale bar corresponds to 20 mm.
doi:10.1371/journal.pone.0034412.g003
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Materials and Methods
Mouse studies
PTP1B-floxed (PTP1Bfl/fl) mice were generated previously [55].
Adiponectin (Adipoq)-Cre mice were obtained from Dr. E. Rosen
(BIDMC/Harvard University). Mice were maintained on a 12-
hour light-dark cycle in a temperature-controlled facility, with free
access to water and food. Mice were fed high fat diet (HFD; 60%
Kcal from fat, Cat # D12492, Research Diets) at weaning.
Genotyping for the PTP1B floxed allele and presence of Cre was
performed by polymerase chain reaction (PCR), using DNA
extracted from tails [55]. All mouse studies were approved by the
Institutional Animal Care and Use Committee at the University of
California Davis.
Cell culture
Primary brown preadipocytes were isolated from wild type and
whole-body PTP1B KO mice and immortalized as previously
described [42,56,57]. PTP1B KO cells were retrovirally reconsti-
tuted with wild type human (h) PTP1B (WT) or substrate-trapping
mutant D181A (D/A) as we previously described [44]. Cells were
induced to differentiate into brown adipocytes with massive
accumulation of multilocular fat droplets using established
protocols [56,58]. ER stress was induced in differentiated
adipocytes by treatment with tunicamycin (2 ng/ml) or thapsi-
gargin (1 mM). PERK2/2 and PERK+/+ fibroblasts were
cultured as previously described [59].
Figure 4. Enhanced ATF4 mRNA translation in PTP1B-deficient differentiated brown adipocytes. Differentiated WT (A, B) and PTP1B KO
(C, D) brown adipocytes were left untreated (A, C) or treated (B, D) with thapsigargin (TG, 1 mM) for 2 hr followed by polysome profile analysis using
20–50% sucrose gradients as described in Methods. Gradients were fractionated from top (fraction 1) to bottom (fraction 17). Absorbance of the
gradients was measured continuously at 264 nm to provide the polysome profiles. Association of ATF4 mRNA and GAPDH mRNA with the ribosomal
interface was detected by RT-PCR. Data present one of two reproducible experiments. E) Protein synthesis in differentiated WT, KO and D/A brown
adipocytes before and after TG treatment. Bar chart represents newly incorporated 35S methionine from three independent experiments. (*) indicates
significant difference between KO and D/A versus WT at the corresponding treatment time and (#) indicates significant difference between treated
and non-treated cells within each group.
doi:10.1371/journal.pone.0034412.g004
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Biochemical analyses
Brown adipose tissues were ground in the presence of liquid
nitrogen and lysed using radio-immunoprecipitation assay (RIPA)
buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.1% sodium
dodecyl sulfate [SDS], 1% Triton X-100, 1% sodium deoxycho-
late, 5 mM EDTA, 1 mM NaF, 1 mM sodium orthovanadate and
protease inhibitors). Lysates were clarified by centrifugation at
13,000 rpm for 10 min, and protein concentrations were deter-
mined using a bicinchoninic acid protein assay kit (Pierce
Chemical). For differentiated brown adipocytes, cells were lysed
in RIPA and extracts were sonicated then clarified as indicated
before. For substrate-trapping experiments, cells were lysed in 1%
NP40 buffer with a protease inhibitor cocktail (without sodium
pervanadate). Immune complexes were collected on protein G-
Sepharose beads (GE Healthcare) and washed with lysis buffer.
Proteins were resolved by SDS-PAGE and transferred to PVDF
membranes. Immunoblots were performed with phospho-tyrosine
antibodies 4G10 (Upstate Biotechnology) and PY99, or antibodies
against p-PERK (Thr980), PERK, p-eIF2a (Ser51), eIF2a,
sXBP1, ATF6a, BiP and CHOP (all from Santa Cruz Biotech-
nology). Anti-p-PERK (Tyr615) antibodies were previously
described [14]. Proteins were visualized using enhanced chemilu-
minescence (ECL, Amersham Biosciences) and pixel intensities of
immuno-reactive bands were quantified using FluorChem 9900
(Alpha Innotech, CA).
Total RNA was extracted from BAT and differentiated
adipocytes using TRIzol reagent (Invitrogen). cDNA was gener-
ated using high-capacity cDNA Archive Kit (SuperScriptTM III
Reverse Transcriptase, Invitrogen). mRNA of BiP, spliced
(s)XBP1, CHOP, and ATF4 was assessed by quantitative reverse
transcription PCR (iCycler, BioRad) with appropriate primers
(Table S1) and normalized to glyceraldehyde 3-phosphate
dehydrogenase (GAPDH).
Polysome profile analyses
Polysome profiles and detection of mRNAs by RTPCR were
performed as previously described [51,60]. Briefly, cytoplasmic
extracts of differentiated cells with and without thapsigargin
treatment were carefully layered over 10 to 50% linear sucrose
gradients in polysome buffer (300 mM NaCl, 150 mM Tris,
pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 50 U of recombinant
RNasin, and 0.5% sodium deoxycholate) and centrifuged at
40,000 rpm in a Beckman SW40Ti rotor for 2.5 h at 4uC.
Gradients were fractionated using an ISCO gradient fractionation
system equipped with a UA-6 detector following an upward
displacement method. Light RNP fractions, 40S, 60S, 80S, and
heavy polysome fractions were monitored by continuous UV
absorption profiles at absorbance of 264 nm and 800 ml fractions
were collected. mRNAs from the translationally active (polysome)
and silenced pools (mRNP/monosome) were isolated from the
fractions and ATF4 expression determined using RT-PCR.
[35S] metabolic pulse labeling
Protein synthesis was measured as previously described [61].
Briefly, differentiated adipocytes were starved overnight in
DMEM lacking methionine and supplemented with 10% dialyzed
fetal bovine serum. Tran35S-label (ICN) was then added to the
cells at concentration of 100 mCi/106 cells for 30 min followed by
thapsigargin treatment for 2 hrs. Cells were washed with PBS then
lysed in RIPA buffer. 250 mg of total protein were precipitated
using trichloroacetic acid at concentration of 10% w/v, washed
with 300 ml of acetone, resuspended in 100 ml of PBS-2% SDS
and transferred to 4.9 ml of scintillation fluid. The incorporated
radioactivity was quantitated using liquid scintillation counting.
Statistical analyses
Data are expressed as means 6 standard error of the mean
(SEM). All statistical analyses were performed using JMP
Statistical Discovery (SAS Institute). For experiments on mouse
tissues, statistical analyses were performed using one-way ANOVA
and Bonferroni-Holmes method for Post hoc analysis. For
experiments on cells, statistical analyses were performed using
Student’s t test. A symbol (such as *) indicates P#0.05, whereas a
duplicate symbol (such as **) indicates P#0.01.
Supporting Information
Figure S1 ER stress induction leads to increased PTP1B
expression in adipose tissue and adipocytes. A) Immuno-
blots of PTP1B in brown (upper panel) and subcutaneous (lower
panel) adipose tissue depots from mice fed chow and HFD for 3 or
11 weeks. Each lane represents adipose tissue from a different
animal. B) PTP1B expression in differentiated brown (upper
panel) and white (lower panel) adipocytes upon exposure to
0.5 mM palmitate for the indicated times. Blots were reprobed for
Tubulin to control for loading. Bar charts represent PTP1B
expression normalized to Tubulin. In panel A (*) indicates
significant difference between chow and HFD fed mice in BAT
and SQ depot. In panel B (*) indicates significant difference
between palmitate-treated and non-treated cells.
(TIF)
Figure S2 Enhanced UPR in PTP1B-deficient WAT
depots. Immunoblots of p-PERK (Thr980), PERK, p-eIF2a
(Ser51), eIF2a, BiP, sXBP1, cATF6a and CHOP in subcutaneous
(A) and retroperitoneal (B) adipose depots from fl/fl and adipose-
PTP1B KO mice fed HFD for 26 weeks. Lysates were also probed
for Tubulin to control for loading. Each lane represents tissue from
a different animal. Bar charts represent p-PERK (Thr980) and p-
eIF2a (Ser51) normalized to their protein expression, BiP, sXBP1,
cATF6a and CHOP normalized to Tubulin. Data represent
means 6 SEM from at least five different mice per genotype. (*)
indicates significant difference between KO and fl/fl mice.
(TIF)
Figure S3 Enhanced PERK/eIF2a phosphorylation in
PTP1B-deficient brown adipocytes exposed to tunica-
mycin. Differentiated brown adipocytes were treated with
tunicamycin (TN; 2 ng/ml) for 12 or 24 hours. (A) Immunoblots
of p-PERK (Thr980), PERK, p-eIF2a (Ser51), eIF2a, BiP and
CHOP in lysates of differentiated WT, KO and D/A adipocytes.
BiP (B), sXBP1 (C) and CHOP (D) mRNA was measured by
quantitative real-time PCR and normalized against GAPDH.
Data represent means 6 SEM of three independent experiments.
(*) indicates significant difference between KO and D/A versus
WT at the corresponding time, (#) indicates significant difference
between treated and non-treated cells within each group, and (‘)
indicates significant difference between KO and D/A at the
corresponding time.
(TIF)
Table S1 Primers sequences used for real time PCR.
(TIF)
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